Neurotoxicity of engineered nanoparticles from metals

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 1, 2012, Pages 65-80

  Sharma, Hari Shanker ^a   Sharma, Aruna ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aluminum; Astrocytes; Blood brain barrier; Brain edema; Brain pathology; Cerebral blood flow; Cognitive functions; Copper; Engineered nanoparticles; Myelin; Neuropathology; Sensory motor functions; Silver

Indexed keywords

ALBUMIN; ALUMINUM NANOPARTICLE; COPPER NANOPARTICLE; CYANOACRYLATE DERIVATIVE; EVANS BLUE; HEAT SHOCK PROTEIN; IODINE 125; LANTHANUM; METAL NANOPARTICLE; MYELIN; NANOCARRIER; POLYSORBATE 80; POTASSIUM ION; SILVER NANOPARTICLE; SODIUM ION; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CELL; BRAIN DAMAGE; BRAIN EDEMA; BRAIN LEVEL; CELL ULTRASTRUCTURE; COGNITION; CONCENTRATION (PARAMETERS); DRUG TRANSPORT; ENDOTHELIUM CELL; EXTRAVASATION; GLIA CELL; HISTOPATHOLOGY; HUMAN; MATERIAL COATING; MEMBRANE PERMEABILITY; MICROVASCULATURE; NANOENGINEERING; NEUROPIL; NEUROTOXICITY; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; REVIEW; SPINAL CORD; SURFACE CHARGE;

EID: 84860343496     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712799960817     Document Type: Review

References (112)

1. Sharma, H.S. A special section on nanoneuroscience: nanoneurotoxicity and nanoneuroprotection. J. Nanosci. Nanotechnol., 2009, 9(8), 4992-4995.
2. Sharma, H.S. Nanoneuroscience and nanoneuropharmacology, Prog. Brain Res., 2009, 180, 1-267.
3. Glenn, J.C. Nanotechnology: Future military environmental health considerations. Technol. Forecasting Soc. Change, 2006, 73(2), 128-137.
4. Song, Y.; Tang, S. Nanoexposure, unusual diseases, and new health and safety concerns. Sci. World J., 2011, 11, 1821-1828.
5. [Zhang, R.; Bai, Y.; Zhang, B.; Chen, L.; Yan, B. The potential health risk of titania nanoparticles. J. Hazard. Mater., 2011, [Epub ahead of print].
6. Kulvietis, V.; Zalgeviciene, V.; Didziapetriene, J.; Rotomskis, R. Transport of Nanoparticles through the Placental Barrier. Tohoku J. Exp. Med., 2011, 225(4), 225-234.
7. [Jachak, A.; Lai, S.K.; Hida, K.; Suk, J.S.; Markovic, N.; Biswal, S.; Breysse, P.N.; Hanes, J. Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology, 2011, [Epub ahead of print].
8. Könczöl, M.; Ebeling, S.; Goldenberg, E.; Treude, F.; Gminski, R.; Gieré, R.; Grobéty, B.; Rothen-Rutishauser, B.; Merfort, I.; Mersch-Sundermann, V. Cytotoxicity and genotoxicity of sizefractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem. Res. Toxicol., 2011, 24(9), 1460-1475.
9. Sun, J.; Wang, S.; Zhao, D.; Hun, F.H.; Weng, L.; Liu, H. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol. Toxicol., 2011, 27(5), 333-342.
10. Peters, A.; Rückerl, R.; Cyrys, J. Lessons from air pollution epidemiology for studies of engineered nanomaterials. J. Occup. Environ. Med., 2011, 53(6 Suppl), S8-S13.
11. Eisen, E.A.; Costello, S.; Chevrier, J.; Picciotto, S. Epidemiologic challenges for studies of occupational exposure to engineered nanoparticles; a commentary. J. Occup. Environ. Med., 2011, 53(6 Suppl), S57-S61.
12. Heng, B.C.; Zhao, X.; Tan, E.C.; Khamis, N.; Assodani, A.; Xiong, S.; Ruedl, C.; Ng, K.W.; Loo, J.S. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch. Toxicol., 2011, 85(12), 1517-1528.
13. Sharma, H.S.; Muresanu, D.F.; Patnaik, R.; Stan, A.D.; Vacaras, V.; Perju-Dumbrav, L.; Alexandru, B.; Buzoianu, A.; Opincariu, I.; Menon, P.K.; Sharma, A. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J. Nanosci. Nanotechnol., 2011, 11(9), 7549-7569.
14. Sharma, H.S.; Patnaik, R.; Sharma, A. Diabetes aggravates nanoparticles induced breakdown of the blood-brain barrier permeability, brain edema formation, alterations in cerebral blood flow and neuronal injury. An experimental study using physiological and morphological investigations in the rat. J. Nanosci. Nanotechnol., 2010, 10(12), 7931-7945.
15. Sharma, H.S.; Sharma, A. Nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine (Lond.), 2010, 5(4), 533-537.
16. Sharma, H.S.; Hussain, S.; Schlager, J.; Ali, S.F.; Sharma, A. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir. Suppl., 2010, 106, 359-364.
17. Sharma, H.S.; Sharma, A.; Hussain, S.; Schlager, J.; Sjöquist, P.O.; Muresanu, D. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia. Acta Neurochir. Suppl., 2010, 106, 351-357.
18. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Sharma, A.; Boman, A.; Lek, P.; Seifert, E.; Lundstedt, T. Nanowired-drug delivery enhances neuroprotective efficacy of compounds and reduces spinal cord edema formation and improves functional outcome following spinal cord injury in the rat. Acta Neurochir. Suppl., 2010, 106, 343-350.
19. Sharma, H.S.; Ali, S.F.; Hussain, S.M.; Schlager, J.J.; Sharma, A. Influence of engineered nanoparticles from metals on the bloodbrain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 5055-5072.
20. Sharma, H.S.; Ali, S.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Lek, P.; Sharma, A.; Lundstedt, T. Nano-drug delivery and neuroprotection in spinal cord injury. J. Nanosci. Nanotechnol., 2009, 9(8), 5014-5037.
21. Sharma, H.S.; Patnaik, R.; Sharma, A.; Sjöquist, P.O.; Lafuente, J.V. Silicon dioxide nanoparticles (SiO2, 40-50 nm) exacerbate pathophysiology of traumatic spinal cord injury and deteriorate functional outcome in the rat. An experimental study using pharmacological and morphological approaches. J. Nanosci. Nanotechnol., 2009, 9(8), 4970-4980.
22. Sharma, H.S.; Muresanu, D.F.; Sharma, A.; Patnaik, R.; Lafuente, J.V. Nanoparticles influence pathophysiology of spinal cord injury and repair. Prog. Brain Res., 2009, 180, 154-180.
23. Altman, J.; Gubrud, M. Anticipating military nanotechnology. IEEE Technol. Soc. Mag., 2004, 33-40.
24. Sharma, H.S.; Sharma, A. Nanowired drug delivery for neuroprotection in central nervous system injuries, modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2012, 4(2), 184-203.
25. Lanone, S.; Boczkowski, J. Biomedical applications and potential health risks of nanomaterials, molecular mechanisms. Curr. Mol. Med., 2006, 6(6), 651-663.
26. Wagner, V.; Dullaart, A.; Bock, A.K.; Zweck, A. The emerging nanomedicine landscape. Nat. Biotechnol., 2006, 24(10), 1211-1217.
27. Euliss, L.E.; Dupont, J.A.; Gratton, S.; Desimone, J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev., 2006, 35(11), 1095-1104.
28. Farokhzad, O.C.; Langer, R. Nanomedicine, Developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev., 2006, 58(14), 1456-1459.
29. Mertens, H.; Biteen, J.S.; Atwater, H.A.; Polman, A. Polarizationselective plasmon-enhanced silicon quantum-dot luminescence. Nano Lett., 2006, 6(11), 2622-2625.
30. Sharma, H.S.; Ali, S.F.; Dong, W.; Tian, Z.R.; Patnaik, R.; Patnaik, S.; Sharma, A.; Boman, A.; Lek, P.; Seifert, E.; Lundstedt, T. Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord. Ann. NY Acad. Sci., 2007, 1122, 197-218.
31. Williams, D. Quantum dots in medical technology. Med. Device Technol., 2006, 17(4), 8-9.
32. Fang, J.Y. Nano- or submicron-sized liposomes as carriers for drug delivery. Chang. Gung. Med. J., 2006, 29(4), 358-362.
33. He, W.; Yong, T.; Ma, Z.W.; Inai, R.; Teo, W.E.; Ramakrishna, S. Biodegradable polymer nanofiber mesh to maintain functions of endothelial cells. Tissue Eng., 2006, 12(9), 2457-2466.
34. Moghimi, S.M. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anticancer Agents Med. Chem., 2006, 6(6), 5535-5561.
35. Borm, P.J.; Robbins, D.; Haubold, S.; Kuhlbusch, T.; Fissan, H.; Donaldson, K.; Schins, R.; Stone, V.; Kreyling, W.; Lademann, J.; Krutmann, J.; Warheit, D.; Oberdorster, E. The potential risks of nanomaterials, a review carried out for ECETOC. Part. Fibre Toxicol., 2006, 3, 11.
36. Zhang, W.W.; Cao, Q.Q.; Xie, J.L.; Ren, X.M.; Lu, C.S.; Zhou, Y.; Yao, Y.G.; Meng, Q.J. Structural, morphological, and magnetic study of nanocrystalline cobalt-nickel-copper particles. J. Colloid. Interface Sci., 2003, 257(2), 237-243.
37. Sharma, H.S.; Sharma, A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog. Brain Res., 2007, 162, 245-273.
38. Koziara, J.M.; Lockman, P.R.; Allen, D.D.; Mumper, R.J. The blood-brain barrier and brain drug delivery. J. Nanosci. Nanotechnol., 2006, 6(9-10), 2712-2735
39. Mills, N.L.; Amin, N.; Robinson, S.D.; Anand, A.; Davies, J.; Patel, D.; de la Fuente, J.M.; Cassee, F.R.; Boon, N.A.; Macnee, W.; Millar, A.M.; Donaldson, K.; Newby, D.E. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Respir. Crit. Care Med., 2006, 173(4), 426-431.
40. Lam, C.W.; James, J.T.; McCluskey, R.; Arepalli, S.; Hunter, R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol., 2006, 36(3), 189-217.
41. Kim, J.S.; Yoon, T.J.; Yu, K.N.; Kim, B.G.; Park, S.J.; Kim, H.W.; Lee, K.H.; Park, S.B.; Lee, J.K.; Cho, M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci., 2006, 89(1), 338-347.
42. Dunning, M.D.; Lakatos, A.; Loizou, L.; Kettunen, M.; ffrench- Constant, C.; Brindle, K.M.; Franklin, R.J. Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS. J. Neurosci., 2004, 24(44), 9799-9810.
43. Pries, A.R.; Kuebler, W.M. Normal endothelium. Handb. Exp. Pharmacol., 2006, (176 Pt 1), 1-40.
44. Kreuter, J.; Alyautdin, R.N.; Kharkevich, D.A.; Ivanov, A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res., 1995, 674(1), 171-174.
45. Alyautdin, R.N.; Petrov, V.E.; Langer, K.; Berthold, A.; Kharkevich, D.A.; Kreuter, J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res., 1997, 14(3), 325-328.
46. Schroder, U.; Sabel, B.A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res., 1996, 710(1-2), 121-124.
47. Olivier, J.C. Drug transport to brain with targeted nanoparticles. NeuroRx, 2005, 2(1), 108-119.
48. Friese, A.; Seiller, E.; Quack, G.; Lorenz, B.; Kreuter, J. Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system. Eur. J. Pharm. Biopharm., 2000, 49(2), 103-109.
49. Gao, K.; Jiang, X. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int. J. Pharm., 2006, 310(1-2), 213-219.
50. Calvo, P.; Gouritin, B.; Chacun, H.; Desmaele, D.; D'Angelo, J.; Noel, J.P.; Georgin, D.; Fattal, E.; Andreux, J.P.; Couvreur, P. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res., 2001, 18(8), 1157-1166.
51. Tiwari, S.B.; Amiji, M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv., 2006, 3(2), 219-232.
52. Liu, G.; Men, P.; Harris, P.L.; Rolston, R.K.; Perry, G.; Smith, M.A. Nanoparticle iron chelators, a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci. Lett., 2006, 406(3), 189-193.
53. Kreuter, J. Influence of the surface properties on nanoparticlemediated transport of drugs to the brain. J. Nanosci. Nanotechnol., 2004, 4(5), 484-488.
54. Zheng, G.; Chen, J.; Li, H.; Glickson, J.D. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. USA 2005, 102(49), 17757-17762.
55. Hagenbuch, B.; Meier, P.J. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta, 2003, 1609(1), 1-18.
56. Fenart, L.; Casanova, A.; Dehouck, B.; Duhem, C.; Slupek, S.; Cecchelli, R.; Betbeder, D. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J. Pharmacol. Exp. Ther., 1999, 291(3), 1017-1022.
57. Nagy, Z.; Peters, H.; Huttner, I. Charge-related alterations of the cerebral endothelium. Lab. Invest., 1983, 49(6), 662-671.
58. [Hardebo, J.E., Kåhrström, J. Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiol. Scand., 1985, 125, 495-499.
59. Lockman, P.R.; Koziara, J.M.; Mumper, R.J.; Allen, D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target, 2004, 12(9-10), 635-641.
60. Saija, A.; Princi, P.; Trombetta, D.; Lanza, M.; De Pasquale, A. Changes in the permeability of the blood-brain barrier following sodium dodecyl sulphate administration in the rat. Exp. Brain Res., 1997, 115(3), 546-551.
61. Koziara, J.M.; Lockman, P.R.; Allen, D.D.; Mumper, R.J. The blood-brain barrier and brain drug delivery. J. Nanosci. Nanotechnol., 2006, 6(9-10), 2712-2735.
62. Koziara, J.M.; Lockman, P.R.; Allen, D.D.; Mumper, R.J. In situ blood-brain barrier transport of nanoparticles. Pharm. Res., 2003, 20(11), 1772-1778.
63. Sahagun, G.; Moore, S.A.; Hart, M.N. Permeability of neutral vs anionic dextrans in cultured brain microvascular endothelium. Am. J. Physiol., 1990, 259(1 Pt 2), H162-H166.
64. Kim, J.S.; Yoon, T.J.; Yu, K.N.; Noh, M.S.; Woo, M.; Kim, B.G.; Lee, K.H.; Sohn, B.H.; Park, S.B.; Lee, J.K.; Cho, M.H. Cellular uptake of magnetic nanoparticle is mediated through energydependent endocytosis in A549 cells. J. Vet. Sci., 2006, 7(4), 321-326.
65. Kniesel, U.; Wolburg, H. Tight junctions of the blood-brain barrier. Cell Mol. Neurobiol., 2000, 20(1), 57-76.
66. Ambruosi, A.; Yamamoto, H.; Kreuter, J. Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats. J. Drug Target, 2005, 13(10), 535-542.
67. Teeguarden, J.G.; Hinderliter, P.M.; Orr, G.; Thrall, B.D.; Pounds, J.G. Particokinetics in vitro, dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci., 2006, 95(2), 300-312.
68. Xia, T.; Kovochich, M.; Brant, J.; Hotze, M.; Sempf, J.; Oberley, T.; Sioutas, C.; Yeh, J.I.; Wiesner, M.R.; Nel, A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett., 2006, 6(8), 1794-1807.
69. Kürbitz, S.; Porstendorfer, J.; Berg, K.-J.; Berg, G. Determination of size and concentration of copper nanoparticles dispersed in glasses using spectroscopic ellipsometry. Appl. Phys. B Lasers Opt., 2001, 73(4), 333-337.
70. Amidi, M.; Romeijn, S.G.; Borchard, G.; Junginger, H.E.; Hennink, W.E.; Jiskoot, W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release, 2006, 111(1-2), 107-116.
71. Fabian, E.; Landsiedel, R.; Ma-Hock, L.; Wiench, K.; Wohlleben, W.; van Ravenzwaay, B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol., 2008, 82(3), 151-157.
72. Sharma, H.S.; Dey, P.K. Probable involvement of 5- hydroxytryptamine in increased permeability of blood-brain barrier under heat stress in young rats. Neuropharmacology, 1986, 25(2), 161-167.
73. Sharma, H.S. Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral blood flow in normotensive rats. Neuropharmacology, 1987, 26(1), 85-92.
74. Sharma, H.S.; Olsson, Y.; Dey, P.K. Early accumulation of serotonin in rat spinal cord subjected to traumatic injury. Relation to edema and blood flow changes. Neuroscience, 1990, 36(3), 725-730.
75. Sharma, H.S.; Olsson, Y.; Dey, P.K. Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res., 1990, 517(1-2), 215-223.
76. Dey, P.K.; Sharma, H.S. Influence of ambient temperature and drug treatments on brain oedema induced by impact injury on skull in rats. Ind. J. Physiol. Pharmacol., 1984, 28(3), 177-186.
77. Sharma, H.S.; Patnaik, R.; Patnaik, S.; Mohanty, S.; Sharma, A.; Vannemreddy, P. Antibodies to serotonin attenuate closed head injury induced blood brain barrier disruption and brain pathology. Ann. NY Acad. Sci., 2007, 1122, 295-312.
78. Rapoport, S.I. Blood-Brain Barrier in Physiology and Medicine; Raven Press, NY, 1976.
79. Sharma, H.S.; Olsson, Y. Edema formation and cellular alterations following spinal cord injury in the rat and their modification with p-chlorophenylalanine. Acta Neuropathol., 1990, 79(6), 604-610.
80. Kiyatkin, E.A.; Brown, P.L.; Sharma, H.S. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication, critical role of brain hyperthermia. Eur. J. Neurosci., 2007, 26(5), 1242-1253.
81. Sharma, H.S.; Sjöquist, P.O. A new antioxidant compound H-290/51 modulates glutamate and GABA immunoreactivity in the rat spinal cord following trauma. Amino Acids, 2002, 23(1-3), 261-272.
82. Sharma, H.S.; Kiyatkin, E.A. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat, An experimental study using light and electron microscopy. J. Chem. Neuroanat., 2009, 37(1), 18-32.
83. Sharma, H.S.; Zimmer, C.; Westman, J.; Cervós-Navarro, J. Acute systemic heat stress increases glial fibrillary acidic protein immunoreactivity in brain, experimental observations in conscious normotensive young rats. Neuroscience, 1992, 48(4), 889-901.
84. Sharma, H.S.; Olsson, Y.; Cervós-Navarro, J. Early perifocal cell changes and edema in traumatic injury of the spinal cord are reduced by indomethacin, an inhibitor of prostaglandin synthesis. Experimental study in the rat. Acta Neuropathol., 1993, 85(2), 145-153.
85. Sharma, H.S.; Olsson, Y.; Westman, J. A serotonin synthesis inhibitor, p-chlorophenylalanine reduces the heat shock protein response following trauma to the spinal cord, an immunohistochemical and ultrastructural study in the rat. Neurosci. Res., 1995, 21(3), 241-249.
86. Sharma, H.S.; Ali, S.F. Alterations in blood-brain barrier function by morphine and methamphetamine. Ann. NY Acad. Sci., 2006, 1074, 198-224.
87. Gordh, T.; Chu, H.; Sharma, H.S. Spinal nerve lesion alters bloodspinal cord barrier function and activates astrocytes in the rat. Pain, 2006, 124(1-2), 211-221.
88. Sharma, H.S. Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches. J. Neural Transm., 2006, 113(4), 497-519.
89. Sharma, H.S. Methods to produce hyperthermia-induced brain dysfunction. Prog. Brain Res., 2007, 162, 173-199.
90. Sharma, H.S.; Ali, S.F.; Tian, Z.R.; Hussain, S.; Schlager, J.; Sjöquist, P.-O.; Sharma, A.; Muresanu, D.F. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. neuroprotective effects of nanowired-antioxidant compound H-290/51. J. Nanosci. Nanotechnol., 2009, 9(8), 5073-5090.
91. Oberdorster, G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal. Toxicol., 1996, 8(Suppl), 73-89.
92. Cavagna, G.; Finulli, M.; Vigliani, E.C. Experimental study on the pathogenesis of fevers caused by the inhalation of Teflon (polytetrafluoroethylene) fumes. Med. Lav., 1961, 52, 251-261.
93. Coleman, W.E.; Scheel, L.D.; Kupel, R.E.; Larkin, R.L. The identification of toxic compounds in the pyrolysis products of polytetrafluoroethylene (PTFE). Am. Ind. Hyg. Assoc. J., 1968, 29(1), 33-40
94. Griffith, F.D.; Stephens, S.S.; Tayfun, F.O. Exposure of Japanese quail and parakeets to the pyrolysis products of fry pans coated with Teflon and common cooking oils. Am. Ind. Hyg. Assoc. J., 1973, 34(4), 176-178.
95. Johnston, C.J.; Finkelstein, J.N.; Mercer, P.; Corson, N.; Gelein, R.; Oberdorster, G. Pulmonary effects induced by ultrafine PTFE particles. Toxicol. Appl. Pharmacol., 2000, 168(3), 208-215.
96. Johnston, C.J.; Finkelstein, J.N.; Gelein, R.; Baggs, R.; Oberdorster, G. Characterization of the early pulmonary inflammatory response associated with PTFE fume exposure. Toxicol. Appl. Pharmacol., 1996, 140(1), 154-163.
97. Sharma, H.S. Influence of Serotonin on the Blood-Brain and Blood- Spinal Cord Barriers. In: Sharma, H.S.; Westman, J., Eds.; The Blood-Spinal Cord and Brain Barriers in Health and Disease; Elsevier Academic Press, San Diego, 2004, pp. 117-158.
98. Zhu, S.; Oberdorster, E.; Haasch, M.L. Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow. Mar. Environ. Res., 2006, 62(Suppl), S5-S9.
99. Shvedova, A.A.; Kisin, E.R.; Mercer, R.; Murray, A.R.; Johnson, V.J.; Potapovich, A.I.; Tyurina, Y.Y.; Gorelik, O.; Arepalli, S.; Schwegler-Berry, D.; Hubbs, A.F.; Antonini, J.; Evans, D.E.; Ku, B.K.; Ramsey, D.; Maynard, A.; Kagan, V.E.; Castranova, V.; Baron, P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol., 2005, 289(5), L698-L708.
100. Warheit, D.B.; Laurence, B.R.; Reed, K.L.; Roach, D.H.; Reynolds, G.A.; Webb, T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci., 2004, 77(1), 117-125.
101. [Oberdorster, G.; Finkelstein, J.N.; Johnston, C.; Gelein, R.; Cox, C.; Baggs, R.; Elder, A.C. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health Eff. Inst., 2000, (96), 5-74, Discussion 75-86.
102. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology, an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 2005, 113(7), 823-839.
103. Brown, D.M.; Wilson, M.R.; MacNee, W.; Stone, V.; Donaldson, K. Size-dependent proinflammatory effects of ultrafine polystyrene particles, a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol., 2001, 175, 191-199.
104. Fenoglio, I.; Tomatis, M.; Lison, D.; Muller, J.; Fonseca, A.; Nagy, J.B.; Fubini, B. Reactivity of carbon nanotubes, free radical generation or scavenging activity? Free Radic. Biol. Med., 2006, 40(7), 1227-1233.
105. Shvedova, A.A.; Kisin, E.R.; Murray, A.; Kommineni, C.; Vallyathan, V.; Castranova, V. Pro/antioxidant status in murine skin following topical exposure to cumene hydroperoxide throughout the ontogeny of skin cancer. Biochemistry (Mosc.), 2004, 69(1), 23-31.
106. Manna, S.K.; Sarkar, S.; Barr, J.; Wise, K.; Barrera, E.V.; Jejelowo, O.; Rice-Ficht, A.C.; Ramesh, G.T. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett., 2005, 5(9), 1676-1684.
107. Sharma, H.S.; Westman, J.; Nyberg, F. Pathophysiology of brain edema and cell changes following hyperthermic brain injury. Prog. Brain Res., 1998, 115, 351-412.
108. Sharma, H.S. Pathophysiology of the Blood-Spinal Cord Barrier in Traumatic Injury. In: Sharma, H.S.; Westman, J., Eds.; The Blood- Spinal Cord and Brain Barriers in Health and Disease; Elsevier Academic Press, San Diego, 2004, pp. 437-518.
109. Sharma, H.S. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr. Pharm. Des., 2005a, 11(11), 1353-1389.
110. Sharma, H.S. New perspectives for the treatment options in spinal cord injury. Expert Opin. Pharmacother., 2008, 9(16), 2773-2800.
111. Sharma, H.S. Hyperthermia induced brain oedema, current status and future perspectives. Ind. J. Med. Res., 2006b, 123(5), 629-652.
112. Sharma, H.S. Blood-Central Nervous System Barriers: A Gateway to Neurodegeneration, Neuroprotection and Neuroregeneration. Hand Book of Neurochemistry and Molecular Neurobiololgy; Springer, Berlin, New York, 2009, Vol. 24, Ch. 11, pp. 163-209.